• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultromics Gets HCPCS Code for AI-Powered EchoGo Heart Failure Device


An artificial intelligence (AI)-enabled platform that can reportedly diagnose heart failure with preserved ejection fraction (HFpEF) through analysis of a single echocardiogram view, the EchoGo Heart Failure now has a HCPCS code for use of the technology in outpatient settings for Medicare beneficiaries.

A newly issued HCPCS code from the Centers for Medicare and Medicaid Services (CMS) may facilitate wider adoption and reimbursement for use of the artificial intelligence (AI)-enabled EchoGo® Heart Failure device (Ultromics) to aid in detecting heart failure with preserved ejection fraction (HFpEF).

Clinicians may utilize the HCPCS code (C9786), which went into effect on July 1, 2023, for “computer-aided detection” of HFpEF based on echocardiography images, according to CMS.1 Ultromics noted the HCPCS code is designated for outpatient use of the EchoGo® Heart Failure device for Medicare beneficiaries.

“This is a major milestone and will enable hospitals to accelerate the adoption of EchoGo Heart Failure to improve detection of HFpEF within their systems,” noted Ross Upton, Ph.D., the CEO and founder of Ultromics. “Given the prevalence of HFpEF, this is a significant development toward recognizing and detecting a heavily underdiagnosed condition.”

EchoGo Heart Failure, which received FDA 510(k) clearance in December 2022, provides automated detection of HFpEF through AI assessment of a single view of an echocardiogram, according to Ultromics.2 The company noted that recently published research has demonstrated an 87.8 percent sensitivity rate and an 83 percent specificity rate for EchoGo Heart Failure in the diagnosis of HFpEF.3,4


1. Ultromics. CMS establishes HCPCS code for Ultromics EchoGo Heart Failure, accelerating access to precision HFpEF detection. Available at: https://www.prnewswire.com/news-releases/cms-establishes-hcpcs-code-for-ultromics-echogo-heart-failure-accelerating-access-to-precision-hfpef-detection-301869759.html . Published July 5, 2023. Accessed July 6, 2023.

2. Hall J. FDA clears AI-powered echocardiography platform for detecting heart failure with preserved ejection fraction. Diagnostic Imaging. Available at: https://www.diagnosticimaging.com/view/fda-clears-ai-powered-echocardiography-platform-for-detecting-heart-failure-with-preserved-ejection-fraction . Published December 7, 2022. Accessed July 6, 2023.

3. Nikorowitsch J, Bei der Kellen J, Kirchhof P, et al. Applying the ESC 2016, H2 FPEF, and HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population. ESC Heart Fail. 2021;8(5):3603-3612.

4. Sanders-van Wijk S, Aizpurua AB, Brunner-La Rocca HP, et al. The HFA-PEFF and H2FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(5):838-840.

Recent Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Expediting the Management of Incidental Pulmonary Emboli on CT
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.